Arcutis Biotherapeutics, Inc. ARQT Free cash flow margin
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from Arcutis Biotherapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcutis Biotherapeutics, Inc.'s free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcutis Biotherapeutics, Inc.'s free cash flow margin?
- Arcutis Biotherapeutics, Inc. (ARQT) reported free cash flow margin of -52.5% in Q1 2025.
- How has Arcutis Biotherapeutics, Inc.'s free cash flow margin changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s free cash flow margin increased by 71.9% year-over-year, from -186.7% to -52.5%.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s free cash flow margin?
- Over 2 years (2022 to 2024), Arcutis Biotherapeutics, Inc.'s free cash flow margin has grown at a -91.0% compound annual growth rate (CAGR), from -7,000.8% to -57.1%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.